Argoff CE: New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain 2000, Suppl 16:S62-S65.
Argoff CE: Targeted topical peripheral analgesics in the management of pain. Curr Pain Headache Rep 2002, 7:34–38.
Galer BS: Topical medications. In Bonica’s Management of Pain. Edited by Loeser JD. Philadelphia: Lippincott Williams & Wilkins; 2001:1736–1741. This effectively reviews the subject.
Gammaitoni AR, Alvarez NA: 24-hour application of the lidocaine patch 5% for 3 consecutive days is safe and well tolerated in healthy adult men and women [Abstract PO6.20]. Presented at the 54th Annual American Academy of Neurology Meeting. Denver: April 13–20, 2002.
Argoff C, Nicholson B, Moskowitz M, et al.: Effectiveness of lidocaine patch 5% (Lidoderm®) in the treatment of low back pain. Presented at the 10th World Congress on Pain. San Diego: August 17–22, 2002.
Watson CP: Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage 1994, 9:425–433.
Gammaitoni AR, Davis MW: Pharmacokinetics and to lerability of lidocaine 5% patch with extended dosing. Ann Pharmacother 2002, 36:236–240.
Ness TJ, Jones L, Smith H: Use of compounded topical analgesics: results of an Internet survey. Reg Anesth Pain Med 2002, 27:309–312.
Sawynok J: Topical and peripherally acting analgesics. Pharmacol Rev 2003, 55:1–20.
Robbins W: Clinical applications of capsaicinoids. Clin J Pain 2000, Suppl 16:S86-S89. This review examines the potential of these agents as topical analgesics.
Rowbotham MC: Topical analgesic agents. In Pharmacologic Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Edited by Fields HL, Liebeskind JC. Seattle: IASP Press; 1994:211–227.
Cashman JN: The mechanism of action of NSAIDs in analgesia. Drugs 1996, 52(suppl 5):13–23.
Yesilyurt O, Dogrul A, Gul H, et al.: Topical cannabinoid enhances topical morphine antinociception. Pain 2003, 105:303–308.
Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001, 26:21–29. This exciting review suggests some of the less commonly reported mechanisms of antidepressants as analgesics.
Gerner P, Kao G, Srinivasa V, et al.: Topical amitriptyline in health volunteers. Reg Anesth Pain Med 2003, 28:289–293.
Physicians Desk Reference, edn 55. Montvale, NJ: Medical Economics Company; 2002.
Rowbotham MC, Davies PS, Verkempinck, et al.: Lidocaine patch: double-blind, controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996, 65:39–44.
Galer BS, Rowbotham MC, Perander J, et al.: Topical lidocaine patch relieves post-herpetic neuralgia more effectively than vehicle patch: results of an enriched enrollment study. Pain 1999, 80:533–538.
Katz NP, Davis MW, Dworkin RH: Topical lidocaine patch produces a significant improvement in mean pain scores and pain relief in treated PHN patients: results of a multicenter open-label trial. J Pain 2001, 2:9–18.
Meier T, Wasner G, Faust M, et al.: Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003, 106:151–158.
Devers A, Galer BS: Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000, 16:205–208.
Data on file. Endo Pharmaceuticals, Inc. Chadds Ford, PA.
Hart-Gouleau S, Gammaitoni A, Galer BS, et al.: Open-label study of the effectiveness and safety of the lidocaine patch 5% (Lidoderm®) in patients with painful diabetic neuropathy. Presented at the 10th World Congress on Pain. San Diego: August 17–22, 2002.
Galer BS, Jensen MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997, 48:332–338.
Barbano RL, Herrmann DN, Hart-Gouleau S, et al.: Effectiveness, tolerability, and impact on quality of life of lidocaine patch 5% in diabetic polyneuropathy. Arch Neurol, accepted for publication.
Galer BS, Jensen MP, Ma T, et al.: The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain 2002, 18:297–301.
Lycka BA, Watson CP, Nevin K, et al.: EMLA® cream for the treatment of pain caused by post-herpetic neuralgia: a double-blind, placebo-controlled study [Abstract]. Proceedings of the 1996 Annual Meeting of the American Pain Society 1996, A111.
Attal N, Brasseur L, Chauvin M, et al.: Effects of single and repeated applications of a eutectic mixture of local anesthetics (EMLA®) cream on spontaneous and evoked pain in postherpetic neuralgia. Pain 1999, 81:203–209.
Litman SJ, Vitkun SA, Poppers PJ: Use of EMLA® cream in the treatment of post-herpetic neuralgia. J Clin Anesth 1996, 8:54–57.
Lynch ME, Clark AJ, Sawynok J: A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain 2003, 19:323–328.
Quan D, Wellish M, Gilden DH: Topical ketamine treatment of postherpetic neuralgia. Neurology 2003, 60:1391–1392.
Greenway FL, Frome BM, Engels TM, et al.: Temporary relief of post-herpetic neuralgia pain with topical geranium oil. Am J Med 2003, 115:586–587.
Rains C, Bryson HM: Topical capsaicin: a review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy, and osteoarthritis. Drugs Aging 1995, 7:317–328.
Robbins WR, Staats PS, Levine J, et al.: Treatment of intractable pain with topical large-dose capsaicin: preliminary report. Anesth Analg 1998, 86:579–583.
McCleane G: Topical application of doxepin hydrochloride, capsaicin, and a combination of both produces analgesia in chronic neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000, 49:574–579.
Marten M: Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism. Clin Rheumatol 1997, 16:25–31.
Galer BS, Rowbotham MC, Perander J, et al.: Topical diclofenac patch significantly reduces pain associated with minor sports injuries: results of a randomized, double-blind, placebo-controlled, multicenter study. J Pain Symptom Manage 2000, 19:287–294.
Jenoure P, Segesser B, Luhti U, et al.: A trial with diclofenac HEP plaster as topical treatment in minor sports injuries. Drugs Exp Clin Res 1993, 19:125–131.
Bruhlmann P, Michel BA: Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol 2003, 21:193–198.
Campbell J, Dunn T: Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accidental Emerg Med 1994, 11:178–182.
Airaksinen O, Venalainen J, Pietilainen T: Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. Int J Clin Pharmacol Ther Toxicol 1993, 31:561–563.
Machen J, Whitefield M: Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomized, double-blind, placebo-controlled study. Intl J Clin Prac 2002, 56:102–106.
Whitefield M, O’Kane CJ, Anderson S: Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther 2002, 27:409–417.
Ottillinger B, Gomor B, Michel BA, et al.: Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 2001, 9:273–280.
Sandelin J, Harilainen A, Crone H, et al.: Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee: a doubleblind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol 1997, 26:287–292.
Dreiser RL, Tisne-Camus M: DHEP plasters as a topical treatment of knee osteoarthritis: a double-blind, placebo-controlled study. Drugs Exp Clin Res 1993, 19:107–115.
Galeazzi M, Marcolongo R: A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases. Drugs Exp Clin Res 1993, 19:107–115.
Gallachia G, Marcolongo R: Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion. Drugs Exp Clin Res 1993, 19:95–97.
Winocur E, Gavish A, Halachmi M, et al.: Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area. J Orofac Pain 2000, 14:31–36.
Cohen M, Wolfe R, Mai T, et al.: A randomized, double-blind, placebo-controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol 2003, 30:523–528.
Keitel W, Frerick H, Kuhn U, et al.: Capsicum pain plaster in chronic non-specific low back pain. Arzneimittelforschung 2001, 51:896–903.
Lipman AG, Dalpiaz AS, London SP: Topical lidocaine patch therapy for myofascial pain [Abstract 782]. Presented at the Annual Scientific Meeting of the American Pain Society. Baltimore: March 14–17, 2002.
Briggs M, Nelson EA: Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev 2003, 1:CD001177.
Flock P: Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage 2003, 25:547–554.
Zeppetella G, Ribeiro PJ: Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 2003, 25:555–558.
Fassoulaki A, Sarantopoulos C, Melemeni A, et al.: EMLA reduces acute and chronic pain after breast surgery for cancer. Reg Anesth Pain Med 2000, 25:350–355.
Cerchietti LC, Navigante AH, Bonomi MR, et al.: Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002, 95:2230–2236.
Slatkin NE, Rhiner M: Topical ketamine in the treatment of mucositis pain. Pain Med 2003, 4:298–303.
Galeotti N, DeCesare Mannelli L, Mazzanti G, et al.: Menthol: a natural analgesic compound. Neurosci Lett 2002, 322:145–148.
Sandroni P: Central neuropathic itch: a new treatment option? Neurology 2002, 59:778–779.
Backonja M, Malan P, Brady S, et al.: One-hour high concentration trans-capsaicin applications provide durable pain relief in initial and repeat treatment of postherpetic neuralgia. Presented at the 2004 Annual Scientific Meeting of the American Academy of Neurology. San Francisco: April 24–May 1, 2004.
Simpson D, Brown S, Sampson J, et al.: A single application of high-concentration trans-capsaicin leads to 12 weeks of pain relief in HIV-associated distal symmetrical polyneuropathy: results of an open label trail. Presented at the 2004 Annual Scientific Meeting of the American Academy of Neurology. San Francisco: April 24–May 1, 2004.
Lockhart E: Topical combination of amitriptyiline and ketamine for post herpetic neuralgia. J Pain 2004, 3(suppl 1):82.
Bernstein J, Phillips S, Group T: A new topical medication for the adjunctive relief of painful diabetic neuropathy and postherpetic neuralgia. J Pain 2004, 3(suppl 1):82.
With high quality products and considerate service, we will work together with you to enhance your business and improve the efficiency. Please don't hesitate to contact us to get more details of pain relief gel manufacturer.